Recurrent Torsades de Pointes Precipitated by Berberine Supplement
Abbas Mohammadi1, Hesham M Abdalla2, Nicole Falls2
1Department of Cardiovascular Disease, Mayo Clinic, Phoenix, Arizona, USA. Electronic address: https://twitter.com/DrBase_AMD.
Background:
Acquired long QT syndrome and torsades de pointes (TdP) can be triggered by dietary supplements, which do not go through strict safety testing.
Case Summary:
A 61-year-old man had syncope and recurrent TdP (QTc 669 ms), with an initial electrocardiogram phenotype indistinguishable from congenital LQT2. He was taking several over-the-counter supplements including berberine, dihydroberberine, turmeric, and quercetin and had mild hypomagnesemia. Genetic testing for congenital long QT syndrome was negative. Management included defibrillation, intravenous magnesium, supplement discontinuation, nadolol, and a wearable cardioverter-defibrillator. The QT interval normalized, and nadolol was later discontinued without arrhythmia recurrence.
Discussion:
This case illustrates a "multihit" model, in which supplement-mediated cardiac channel blockade, drug interactions increasing supplement exposure, and hypomagnesemia converged to provoke life-threatening arrhythmia.
Take-Home Messages:
Common supplements like berberine can cause TdP through multiple proarrhythmic mechanisms. Thorough evaluation for extrinsic triggers is essential, even when the electrocardiographic phenotype suggests a genetic disorder.
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Desensitization and Tachyphylaxis
Several...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
